Topic starter
24/10/2026 8:53 pm
TL;DR: AI governance in healthcare only works when approval, monitoring, and accountability are embedded into deployment workflows, Asenion notes. Governance for clinical AI has to follow access, evidence, and ownership across the lifecycle.
Editorial analysis by NHI Mgmt Group, based on content published by Asenion: “Asenion Joins DHDP to Power the Future of AI in Healthcare”.
Key questions
Q: Why do AI governance committees matter when models are used in patient care?
A: AI governance committees matter because clinical AI changes workflow, risk, and accountability across multiple teams.
Q: What breaks when AI agent data access is not tied to identity governance?
A: What breaks is accountability.
Q: How should healthcare organisations govern AI when data comes from many systems?
A: Healthcare organisations should govern AI by treating data provenance, access, and workflow ownership as a single control plane.
Practitioner guidance
- Define AI approval gates before production use Require every healthcare AI use case to pass a documented approval path that covers purpose, data scope, risk level, and accountable owner before deployment.
- Map AI system access to named identities Tie training data access, model administration, and deployment permissions to specific human and non-human identities so that every privileged action is attributable.
- Classify models by clinical and compliance risk Use a repeatable risk classification step so that higher-stakes models receive stricter review, monitoring, and change control than low-impact use cases.
Bottom line: AI governance in healthcare only works when approval, monitoring, and accountability are embedded into deployment workflows.
Glossary terms: AI Governance, Governance-to-Deployment Drift, Clinical AI Accountability, AI Management System
Explore further
View Full Forum → | NHI Foundation Course → | Our Services → | Read the full analysis →
This topic was modified 6 days ago by NHI Mgmt Group
25/10/2026 11:12 am
AI governance in healthcare is becoming an operational control problem, not a policy discussion. The article frames governance as the condition that allows AI to scale safely in a regulated environment. That is the right lens: healthcare teams need repeatable approval, monitoring, and accountability mechanisms that survive beyond pilot projects. Practitioners should judge AI governance by whether it can be enforced in production, not by how polished the policy looks.
A few things that frame the scale:
- 52% of respondents see AI security decision-making power shifting toward platform and infrastructure teams rather than the executive suite, according to the 2026 Infrastructure Identity Survey.
- Only 44% of organisations have implemented any policies to manage their AI agents, despite 92% agreeing that governing AI agents is critical to enterprise security, according to the 2026 Infrastructure Identity Survey.
A question worth separating out:
Q: How do organisations know whether AI governance is actually working?
A: AI governance is working when teams can prove that data access, identity permissions, and runtime controls line up with policy in practice. A useful test is whether the organisation can answer who accessed what, through which identity, and whether any out-of-policy movement was blocked or detected in time.
👉 Read our full editorial: Healthcare AI needs lifecycle governance beyond policy and review
This post was modified 6 days ago by NHI Mgmt Group